641 related articles for article (PubMed ID: 17498512)
1. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
2. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
3. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
Choi SS; Diehl AM
Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
Schäffler A; Schölmerich J; Büchler C
Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in nonalcholic fatty liver disease.
Greenfield V; Cheung O; Sanyal AJ
Curr Opin Gastroenterol; 2008 May; 24(3):320-7. PubMed ID: 18408460
[TBL] [Abstract][Full Text] [Related]
6. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes.
Yki-Järvinen H
Dig Dis; 2010; 28(1):203-9. PubMed ID: 20460912
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
Choudhury J; Sanyal AJ
Clin Liver Dis; 2004 Aug; 8(3):575-94, ix. PubMed ID: 15331065
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease.
Hjelkrem MC; Torres DM; Harrison SA
Minerva Med; 2008 Dec; 99(6):583-93. PubMed ID: 19034256
[TBL] [Abstract][Full Text] [Related]
10. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
Verna EC; Berk PD
Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
[TBL] [Abstract][Full Text] [Related]
11. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
Cusi K
Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
Tilg H; Moschen AR
Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and steatosis in humans.
Capeau J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance: a metabolic pathway to chronic liver disease.
Bugianesi E; McCullough AJ; Marchesini G
Hepatology; 2005 Nov; 42(5):987-1000. PubMed ID: 16250043
[TBL] [Abstract][Full Text] [Related]
15. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
Park SH
Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue as a buffer for daily lipid flux.
Frayn KN
Diabetologia; 2002 Sep; 45(9):1201-10. PubMed ID: 12242452
[TBL] [Abstract][Full Text] [Related]
17. Free fatty acids and insulin resistance.
Delarue J; Magnan C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of lipid metabolism in nonalcoholic fatty liver disease.
Cheung O; Sanyal AJ
Semin Liver Dis; 2008 Nov; 28(4):351-9. PubMed ID: 18956291
[TBL] [Abstract][Full Text] [Related]
19. Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease.
Lê KA; Bortolotti M
Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):477-82. PubMed ID: 18542010
[TBL] [Abstract][Full Text] [Related]
20. Evolving trends in nonalcoholic fatty liver disease.
Delgado JS
Eur J Intern Med; 2008 Mar; 19(2):75-82. PubMed ID: 18249301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
